Anuh Pharma Limited has informed the Exchange regarding the approval of Un-audited Financial Results for the quarter ended December 31, 2025 and Granting Authorization to Key Managerial Personnel for determination of materiality of events/ information under Regulation 30(5) of SEBI (LODR) Regulations, 2015.